Why the study?
Whether myocardial fibrosis or inflammation would reverse associated with left ventricular reverse remodeling in idiopathic dilated cardiomyopathy remains unknown.
Does guideline-directed medical therapy improve myocardial tissue reverse remodeling in patients with idiopathic dilated cardiomyopathy?
Does guideline-directed medical therapy improve myocardial tissue reverse remodeling in patients with idiopathic dilated cardiomyopathy?
In patients with idiopathic DCM, baseline imaging characteristics predict LVRR, and guideline-directed medical therapy leads to significant decreases in myocardial T1, matrix, and cell volume.
Answers are grounded in this paper and cite their sources.
T1/matrix reductions associated with LVRR after GDMT; hypothesis-generating for tissue biomarkers in idiopathic DCM.
BACKGROUND: The prognosis of patients with idiopathic dilated cardiomyopathy (DCM) has improved remarkably in recent decades with guideline-directed medical therapy. Left ventricular (LV) reverse remodeling (LVRR) is one of the major therapeutic goals. Whether myocardial fibrosis or inflammation would reverse associated with LVRR remains unknown. METHODS: test, logistic regression analysis, and linear regression analysis. CONCLUSIONS: In patients with idiopathic DCM, the absence of late gadolinium enhancement, lower T2, and extracellular volume values at baseline are significant predictors of LVRR. The myocardial T1, matrix, and cell volume decrease significantly in patients with LVRR after guideline-directed medical therapy. Registration: URL: https://www.clinicaltrials.gov; Unique identifier: ChiCTR1800017058.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: